Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000301344 | SCV000340746 | uncertain significance | not provided | 2016-03-23 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000552574 | SCV000633741 | uncertain significance | Hereditary hemochromatosis | 2022-10-27 | criteria provided, single submitter | clinical testing | This sequence change replaces phenylalanine, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 280 of the TFR2 protein (p.Phe280Leu). This variant is present in population databases (rs151198873, gnomAD 0.1%). This missense change has been observed in individual(s) with hemochromatosis (PMID: 18762941, 21770687). ClinVar contains an entry for this variant (Variation ID: 287086). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt TFR2 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Natera, |
RCV001275100 | SCV001459854 | uncertain significance | Hemochromatosis type 3 | 2020-01-14 | no assertion criteria provided | clinical testing |